How audits, evidence and litigation shape arm’s length outcome

The free 71-page executive summary of Transfer Pricing on Trial — is your transfer pricing position trial-ready, or merely documented?
Ready to go deeper? Get the complete book — $99.00 →
A transfer pricing study may be technically respectable and still fail when tested in an audit or court. The problem is rarely only the method — the problem is proof. By the time a matter reaches audit, objection, appeal or trial, the question is no longer whether the taxpayer selected the right method or benchmark, but whether it can prove, with admissible and credible evidence, that its position reflects an arm’s length outcome. This executive summary is built around one core question: is your transfer pricing position trial-ready, or merely documented?
In eleven compact chapters it follows the dispute lifecycle from documentation to audit, from audit to evidence, and from evidence to trial: the transfer pricing study as a starting point rather than a defence; contemporaneous documentation prepared while corporate memory is fresh; managing the initial audit strategically from the first request for information; insisting on clarity in the letter of findings; the law of evidence — burden of proof, admissibility, hearsay, business records; expert witnesses who assist the court rather than advocate; the trial, the appeal, and the recent substance, DEMPE and anti-avoidance case law reshaping disputes. Each chapter sets out the practical problem, the key points, the risk if the issue is ignored, and what the full book adds.
It is the free lead-in to the full 412-page edition of Transfer Pricing on Trial, which carries the working tools this summary only describes: interviews with senior counsel from the ABD Ltd v CSARS trial, evidence guides, audit templates and rules of engagement, cross-examination examples, the ABD judgment itself, five case studies, and annexures A to R. The summary gives the reader the roadmap; the full book gives the working tools.
“Is your transfer pricing position trial-ready, or merely documented?”Dr Daniel N Erasmus
Tell us where to send it and we’ll email you a personal download link. If it sparks questions, reply to the email — our faculty read these.